Industry NewsCardiNor has secured NOK12 million (US$1.46M) to commercialize first secretoneurin ELISA test
Product NewsRoche announces five new intended uses for key cardiac biomarkers to help identify cardiovascular risk, better diagnose patients and support early treatment
Editorial ArticleKeeping up with COVID-19: Designing novel monitoring assays to tackle the rise of variants
Industry NewsBio-Techne has announced the commercial release of novel DNAscope in situ hybridization assays